Greń Jakub, Gorman Ingmar, Ruban Anastasia, Tylš Filip, Bhatt Snehal, Aixalà Marc
Public Health Department, Institute of Psychiatry and Neurology.
Fluence International.
Exp Clin Psychopharmacol. 2024 Apr;32(2):129-135. doi: 10.1037/pha0000684. Epub 2023 Nov 27.
The use of psychedelics for various purposes was common in different civilizations throughout human history and has been explored scientifically for more than a century. Although the applications of psychedelics show promise in the treatment of various psychiatric and neurological indications, as well as in facilitation of well-being and personal growth, several psychedelic-related risks and challenges have also been identified. Psychedelic integration (PI) refers to various practices that serve to either minimize harms or maximize benefits associated with psychedelic use. PI is also recognized as a substantial part of psychedelic-assisted therapy (PAT), following preparation to and facilitation of the psychedelic experience. In the context of clinical/psychotherapeutic practice, several PI models/methods have already been proposed. However, while a number of these models/methods are theory-driven, or have a history of clinical application, each lack any empirical support and thus cannot be described as evidence based. This is to the disadvantage to countless people who had and who will have their psychedelic experiences in various contexts, as the prevalence of using psychedelics increased in recent years and is expected to grow further. Therefore, consistent with general recommendations for developing and implementing evidence-based mental health practices, this article calls for scientific efforts to the development, examination, and evaluation of psychedelic integration models/methods. This article also briefly summarizes the current literature on psychedelic integration, provides a list of exemplary avenues that research on psychedelic integration might take, as well as anticipates and discusses the limitations and challenges of PI-focused research. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
在人类历史的不同文明中,出于各种目的使用迷幻剂很常见,并且已经进行了一个多世纪的科学探索。尽管迷幻剂的应用在治疗各种精神和神经疾病以及促进幸福感和个人成长方面显示出前景,但也发现了一些与迷幻剂相关的风险和挑战。迷幻剂整合(PI)是指各种旨在将与使用迷幻剂相关的危害降至最低或使益处最大化的实践。PI也被认为是迷幻剂辅助治疗(PAT)的重要组成部分,仅次于迷幻体验的准备和促进阶段。在临床/心理治疗实践的背景下,已经提出了几种PI模型/方法。然而,虽然其中一些模型/方法是理论驱动的,或者有临床应用历史,但每种都缺乏任何实证支持,因此不能被描述为基于证据的。这对无数已经或将要在各种情况下有迷幻体验的人不利,因为近年来使用迷幻剂的流行率有所上升,预计还会进一步增长。因此,与开发和实施基于证据的心理健康实践的一般建议一致,本文呼吁进行科学努力,以开发、检验和评估迷幻剂整合模型/方法。本文还简要总结了当前关于迷幻剂整合的文献,提供了迷幻剂整合研究可能采取的示例性途径列表,并预测和讨论了以PI为重点的研究的局限性和挑战。(PsycInfo数据库记录(c)2024美国心理学会,保留所有权利)